Learn More
Invitrogen™ Collagen VI Recombinant Rabbit Monoclonal Antibody (SD83-03)

Description
Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire.
Specifications
Specifications
| Antigen | Collagen VI |
| Applications | Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry, Western Blot |
| Classification | Recombinant Monoclonal |
| Clone | SD83-03 |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | TBS with 0.05% BSA, 40% Glycerol and 0.05% sodium azide; pH 7.4 |
| Gene | COL6A1 |
| Gene Accession No. | P12109, Q04857 |
| Gene Alias | AI747156; alpha 1 (VI) chain (61 AA); BTHLM1; Col6a1; Col6a-1; Col6a2; Col6a-2; Collagen alpha-1(VI) chain; collagen alpha-2(VI) chain; collagen type VI alpha 1; collagen type VI alpha 2; collagen VI, alpha-1 polypeptide; collagen VI, alpha-2 polypeptide; collagen, type VI, alpha 1; collagen, type VI, alpha 2; human mRNA for collagen VI alpha-2 C-terminal globular domain; OPLL; PP3610; procollagen, type VI, alpha 1; procollagen, type VI, alpha 2; RGD1565398; UCHMD1; UCMD1 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.